Search Results - "McCoy, Ian E."

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Absence of long-term changes in urine biomarkers after AKI: findings from the CRIC study by McCoy, Ian E, Hsu, Jesse Y, Bonventre, Joseph V, Parikh, Chirag R, Go, Alan S, Liu, Kathleen D, Ricardo, Ana C, Srivastava, Anand, Cohen, Debbie L, He, Jiang, Chen, Jing, Rao, Panduranga S, Muiru, Anthony N, Hsu, Chi-Yuan

    Published in BMC nephrology (13-09-2022)
    “…Mechanisms by which AKI leads to CKD progression remain unclear. Several urine biomarkers have been identified as independent predictors of progressive CKD. It…”
    Get full text
    Journal Article
  2. 2

    Meaning and Management of Perioperative Oliguria by Tallarico, Roberta Teixeira, McCoy, Ian E, Dépret, Francois, Legrand, Matthieu

    Published in Anesthesiology (Philadelphia) (01-02-2024)
    “…Perioperative oliguria is an alarm signal. The initial assessment includes closer patient monitoring, evaluation of volemic status, risk–benefit analysis of…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Initial Management and Potential Opportunities to Deprescribe Dialysis among Patients with AKI-D Patients after Hospital Discharge by McCoy, Ian E, Weinhandl, Eric, Hussein, Wael, Hsu, Chi-Yuan

    “…Dialysis-requiring AKI (AKI-D) now accounts for more than 15% of outpatient hemodialysis initiations; over 30% of these patients with AKI-D may have potential…”
    Get more information
    Journal Article
  5. 5

    AKI—A Relevant Safety End Point? by McCoy, Ian E., Chertow, Glenn M.

    Published in American journal of kidney diseases (01-04-2020)
    “…Acute kidney injury (AKI) is a common outcome evaluated in clinical studies, often as a safety end point in a variety of cardiovascular, kidney disease, and…”
    Get full text
    Journal Article
  6. 6

    Barriers to ACEI/ARB Use in Proteinuric Chronic Kidney Disease: An Observational Study by McCoy, Ian E., Han, Jialin, Montez-Rath, Maria E., Chertow, Glenn M.

    Published in Mayo Clinic proceedings (01-08-2021)
    “…To assess present angiotensin-converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) use among patients with proteinuric chronic kidney…”
    Get full text
    Journal Article
  7. 7

    Central venous pressure and the risk of diuretic-associated acute kidney injury in patients after cardiac surgery by McCoy, Ian E., Montez-Rath, Maria E., Chertow, Glenn M., Chang, Tara I.

    Published in The American heart journal (01-03-2020)
    “…When prescribing diuretics in the postcardiac surgical intensive care unit (ICU), clinicians may use central venous pressure (CVP) to assess volume status and…”
    Get full text
    Journal Article
  8. 8

    Submaximal Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Dosing Among Persons With Proteinuria by Chu, Chi D., Powe, Neil R., Estrella, Michelle M., Shlipak, Michael G., McCoy, Ian E., Tuot, Delphine S.

    Published in Mayo Clinic proceedings (01-11-2022)
    “…For persons with proteinuria, angiotensin-converting enzyme inhibitors (ACEis) and angiotensin II receptor blockers (ARBs) are treatment mainstays for reducing…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Reducing Phlebotomy in Hemodialysis Patients: A Quality Improvement Study by McCoy, Ian E., Shieh, Lisa, Fatehi, Pedram

    Published in Kidney medicine (01-07-2020)
    “…Hospitalized patients receiving hemodialysis frequently have routine, daily laboratory studies drawn by peripheral venipuncture-a painful process that damages…”
    Get full text
    Journal Article
  13. 13

    Probing the Association between Acute Kidney Injury and Cardiovascular Outcomes by McCoy, Ian E, Hsu, Jesse Y, Zhang, Xiaoming, Diamantidis, Clarissa J, Taliercio, Jonathan, Go, Alan S, Liu, Kathleen D, Drawz, Paul, Srivastava, Anand, Horwitz, Edward J, He, Jiang, Chen, Jing, Lash, James P, Weir, Matthew R, Hsu, Chi-Yuan

    “…Patients hospitalized with AKI have higher subsequent risks of heart failure, atherosclerotic cardiovascular events, and mortality than their counterparts…”
    Get full text
    Journal Article
  14. 14

    Patient and Provider Characteristics Associated With Sodium–Glucose Cotransporter 2 Inhibitor Prescription in Patients With Diabetes and Proteinuric Chronic Kidney Disease by McCoy, Ian E., Han, Jialin, Montez-Rath, Maria E., Chertow, Glenn M., Rhee, Jinnie J.

    Published in Clinical diabetes (01-07-2020)
    “…Despite accumulating evidence of cardiorenal benefits from sodium–glucose cotransporter 2 (SGLT2) inhibitors, prescription of agents in this drug class may be…”
    Get full text
    Journal Article
  15. 15

    Optimum Care of AKI Survivors Not Requiring Dialysis after Discharge: An AKINow Recovery Workgroup Report by Barreto, Erin F, Cerda, Jorge, Freshly, Bonnie, Gewin, Leslie, Kwong, Y Diana, McCoy, Ian E, Neyra, Javier A, Ng, Jia H, Silver, Samuel A, Vijayan, Anitha, Abdel-Rahman, Emaad M

    Published in Kidney360 (01-01-2024)
    “…AKI survivors experience gaps in care that contribute to worse outcomes, experience, and cost.Challenges to optimal care include issues with information…”
    Get full text
    Journal Article
  16. 16

    Estimated effects of early diuretic use in critical illness by McCoy, Ian E, Montez-Rath, Maria E, Chertow, Glenn M, Chang, Tara I

    Published in Critical care explorations (01-07-2019)
    “…To estimate the effects of diuretic use during the first 24 hours of an intensive care unit stay on in-hospital mortality and other clinical outcomes including…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Reducing Phlebotomy in Hemodialysis Patients: A Quality Improvement StudyPlain-Language Summary by Ian E. McCoy, Lisa Shieh, Pedram Fatehi

    Published in Kidney medicine (01-07-2020)
    “…Rationale & Objective: Hospitalized patients receiving hemodialysis frequently have routine, daily laboratory studies drawn by peripheral venipuncture-a…”
    Get full text
    Journal Article